Centre for Cancer Biomarkers CCBIO

2015 - Rakel Forthun

Born 1983, holds an M.S. in medical cell biology from UiB and in 2012 received her PhD from UiB, focused on acute myelogen leukemia (AML). She was a postdoc in the Gjertsen group until 2015, working on predictive biomarkers for AML treatment, especially related to the drug valproat.

Main content

Rakel Forthun moved on to a researcher position in the Gjertsen group.

Contact information to Rakel Forthun.

Read more about the Gjertsen group.